Literature DB >> 773397

Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.

N Matthews, P J Chalmers, G R Flannery, R C Nairn.   

Abstract

Splenocytes from inbred Wistar rats bearing a syngeneic squamous cell carcinoma (Spl) were fractionated by several techniques to characterize the lymphoid cells cytotoxic to the tumour in vitro. The anti-tumour cytotoxicity is presumably mediated primarily by T lymphocytes because it was greatly reduced by removal of T lymphocytes with heterologous anti-T serum plus complement but not by removal of other cell types. Cytotoxicity could be blocked at the tumour cell but not at the effector cell by sera taken late in tumour growth. Sera taken earlier in tumour growth could induce cytolysis of tumour cells by normal splenocytes but only if the tumour cells were treated with serum and washed before addition of the effector cells. Although splenocytes from normal and tumour-bearing rats were equally effective at lysing antibody-coated target cells it is unlikely that this mechanism is important in vivo as sera from early in tumour growth onwards contained factors (immune complexes?) which inhibited antibody-induced lymphocytolysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 773397      PMCID: PMC2024971          DOI: 10.1038/bjc.1976.41

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  "Spontaneous" cytolysis by normal human lymphocytes of Burkitt's lymphoma cells of the EB2 cell line.

Authors:  N Matthews; B P Maclaurin
Journal:  Aust J Exp Biol Med Sci       Date:  1974-08

2.  Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

3.  Cell-mediated antitumor immune reactions under syngeneic conditions.

Authors:  J C Leclerc; A Senik; E Gomard; F Plata; J P Levy
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

4.  Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Nat New Biol       Date:  1972-08-09

Review 5.  Studies on a gross-virus-induced lymphoma in the rat. I. The cell-mediated immune response.

Authors:  G R Shellam
Journal:  Int J Cancer       Date:  1974-07-15       Impact factor: 7.396

6.  A lymph node weight assay for the graft-versus-host activity of rat lymphoid cells.

Authors:  W L Ford; W Burr; M Simonsen
Journal:  Transplantation       Date:  1970-09       Impact factor: 4.939

7.  The effects of anti-theta antiserum upon graft-versus-host activity of spleen and lymph node cells.

Authors:  H Cantor
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

8.  Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

9.  Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade.

Authors:  G R Flannery; P J Chalmers; J M Rolland; R C Nairn
Journal:  Br J Cancer       Date:  1973-10       Impact factor: 7.640

10.  Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.

Authors:  A P Nind; N Matthews; E A Pihl; J M Rolland; R C Nairn
Journal:  Br J Cancer       Date:  1975-06       Impact factor: 7.640

View more
  3 in total

1.  Rhodamine as a fluorescent probe of lymphocyte activation.

Authors:  R C Nairn; I M Jablonka; J M Rolland; G M Halliday; H A Ward
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

2.  Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system.

Authors:  P J Chalmers; N Matthews; R C Nairn
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

3.  Inhibition of K cell function by human breast cancer sera.

Authors:  N Matthews; R H Whitehead
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.